Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Schmidt

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Plos One|February 23, 2012
The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosomeHenrick Schomacker, Rebecca M Hebner, Jim Boonyaratanakornkit, et al.
Journal of Virology|December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infectionJim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Vaccine|December 20, 2011
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
The Pediatric Infectious Disease Journal|August 11, 2011
The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young childrenRuth A Karron, Roberta Casey, Bhagvanji Thumar, et al.
Expert Review of Respiratory Medicine|August 24, 2011
Progress in the development of human parainfluenza virus vaccinesAlexander C Schmidt, Anne Schaap-Nutt, Emmalene J Bartlett, et al.
Journal of the Pediatric Infectious Diseases Society|January 3, 2023
Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and ChildrenRuth A Karron, Kristi Herbert, Kimberli Wanionek, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
The Journal of Infectious Diseases|August 3, 2013
Experimental infection of adults with recombinant wild-type human metapneumovirusKawsar R Talaat, Ruth A Karron, Bhagvanji Thumar, et al.
Virology|September 11, 2012
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epitheliumAnne Schaap-Nutt, Rachael Liesman, Emmalene J Bartlett, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Plos One|February 23, 2012
The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosomeHenrick Schomacker, Rebecca M Hebner, Jim Boonyaratanakornkit, et al.
Journal of Virology|December 5, 2008
The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infectionJim B Boonyaratanakornkit, Emmalene J Bartlett, Emerito Amaro-Carambot, et al.
Vaccine|December 20, 2011
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
The Pediatric Infectious Disease Journal|August 11, 2011
The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young childrenRuth A Karron, Roberta Casey, Bhagvanji Thumar, et al.
Expert Review of Respiratory Medicine|August 24, 2011
Progress in the development of human parainfluenza virus vaccinesAlexander C Schmidt, Anne Schaap-Nutt, Emmalene J Bartlett, et al.
Journal of the Pediatric Infectious Diseases Society|January 3, 2023
Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and ChildrenRuth A Karron, Kristi Herbert, Kimberli Wanionek, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
The Journal of Infectious Diseases|August 3, 2013
Experimental infection of adults with recombinant wild-type human metapneumovirusKawsar R Talaat, Ruth A Karron, Bhagvanji Thumar, et al.
Virology|September 11, 2012
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epitheliumAnne Schaap-Nutt, Rachael Liesman, Emmalene J Bartlett, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Pageof 6